Intas Pharmaceuticals Limited Terbinafine Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Terbinafine Export Records India — #12 Exporter, 53 Shipments, $274.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Terbinafine

India Pharmaceutical Trade Intelligence

$27.4M292 Suppliers121 CountriesHS 30049099

ExportsIndia → UNITED STATES41.4%India → UNITED KINGDOM10.6%

ImportsCANADA → India$9.7K MALTA → India$7.7K

#1 Buyer: AUROLOGISTICS LLC

Intas Pharmaceuticals Limited — Terbinafine Exporter #12 | $274.7K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Terbinafine Exporter Profile

Indian Pharmaceutical Exporter · #12 for Terbinafine · $274.7K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #12 Indian exporter of Terbinafine with $274.7K in export value and 53 verified shipments. Intas Pharmaceuticals Limited holds a 1.0% market share in Terbinafine exports across 4 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Terbinafine Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Terbinafine export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Terbinafine?

Country	Value	Shipments	Share
NETHERLANDS	$143.7K	30	52.3%
UNITED KINGDOM	$130.8K	13	47.6%
ITALY	$125	9	0.0%
JAMAICA	$0	1	0.0%

Who Are the Top Buyers of Terbinafine from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
BROCACEF NL : HUB	NETHERLANDS	$101.8K	26
ACCORD UK	UNITED KINGDOM	$74.5K	9
TO THE ORDER	UNITED KINGDOM	$56.4K	4
BROCACEF NL HUB	NETHERLANDS	$20.5K	2
BROCACEF NL:EU HUB	NETHERLANDS	$11.2K	1
BROCACEF NL:HUB	NETHERLANDS	$10.3K	1
LABANALYSIS S.R.L	ITALY	$88	6
LABANALYSIS S.R.L.,	ITALY	$24	2
LABANALYSIS S R L	ITALY	$12	1
THE NATIONAL HEALTH FUND	JAMAICA	$0	1

Intas Pharmaceuticals Limited supplies Terbinafine to 10 buyers globally. The largest buyer is BROCACEF NL : HUB (NETHERLANDS), followed by ACCORD UK (UNITED KINGDOM) and TO THE ORDER (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Terbinafine Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI TERBASIL(TERBINAFINE) 250MG 2X14T(ACO-IE AS PER INVOICETBS	$80.5K	24
PHARMA DRUGS & MEDI TERBINAFINE 250MG 2X14T(ACCORD-UK AS PER INVOICETBS	$74.5K	9
PHARM DRUG&MED:TERBINAFINE 250MG 2X14T(ACCORD-UK )EACH UNCOATED TABLET CONT:TERBINAFINE HYDROCHLORIDE PH.EUR.(ASPERINV)	$56.4K	4
PHARMA DRUGS MEDI TERBASIL TERBINAFINE 250MG 2X14T ACO IE AS PER INVOICE	$20.5K	2
PHARMA DRUGS & MEDI TERBASIL(TERBINAFINE) 250MG 2X14T(ACO-IE AS PER INVOICE	$11.2K	1
PHARM DRUG&MED:TERBASIL(TERBINAFINE) 250MG 2X14T(ACO-IE)EACH UNCOATED TABLET CONT:TERBINAFINE HYDROCHLORIDE PH(ASPERINV)	$11.1K	1
PHARMA DRUG&MED:TERBASIL(TERBINAFINE)250	$10.3K	1
PHARMA DRUGS & MEDI TERBASIL(TERBINAFINE	$10.2K	1
PH.DRU.& MED.: TERBASIL (TERBINAFINE) 250MG TABLETS (EACH UNCOATED TABLET CONTAINS: TERBINAFINE 250MG) [2X14T PER PACK]TBS	$54	4
PH.DRU. & MED.: TERBASIL (TERBINAFINE) 250MG TABLETS (EACH UNCOATED TABLET CONTAINS: TERBINAFINE 250MG) [2X14T PER PACK]	$34	2

Intas Pharmaceuticals Limited exports 13 distinct Terbinafine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI TERBASIL(TERBINAFINE) 250MG 2X14T(ACO-IE with 24 shipments worth $80.5K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Terbinafine Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	AGIO PHARMACEUTICALS LIMITED	$512.1K	53	3	$9.7K
3	BAFNA PHARMACEUTICALS LIMITED	$500.0K	10	1	$50.0K
12	INTAS PHARMACEUTICALS LIMITED ★	$274.7K	53	4	$5.2K
13	MEPRO PHARMACEUTICALS PRIVATE LIMITED	$225.0K	17	6	$13.2K
14	IND-SWIFT LIMITED	$207.0K	8	3	$25.9K

Intas Pharmaceuticals Limited ranks #12 among 292 Indian Terbinafine exporters. Average shipment value of $5.2K compared to the market average of $76.4K. The closest competitors by value are AGIO PHARMACEUTICALS LIMITED and BAFNA PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Terbinafine Exports?

Port	Shipments	% Share
SAHAR AIR	437	14.0%
SAHAR AIR CARGO ACC (INBOM4)	396	12.7%
DELHI AIR CARGO ACC (INDEL4)	354	11.4%
DELHI AIR	275	8.8%
NHAVA SHEVA SEA (INNSA1)	233	7.5%
HYDERABAD ICD (INSNF6)	111	3.6%
JNPT/ NHAVA SHEVA SEA	106	3.4%
Bombay Air	89	2.9%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Terbinafine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Terbinafine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 53 individual customs records matching Intas Pharmaceuticals Limited exporting Terbinafine, covering 13 formulations to 4 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 121+ countries, 589+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Terbinafine

Terbinafine

Intas Pharmaceuticals Limited — Terbinafine Exporter Profile

Intas Pharmaceuticals Limited — Terbinafine Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Terbinafine?

Who Are the Top Buyers of Terbinafine from Intas Pharmaceuticals Limited?

What Is India's Total Terbinafine Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Terbinafine Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Terbinafine Exporters?

What Terbinafine Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Terbinafine to Key Markets

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Terbinafine Exporters?

Which Indian Ports Ship Terbinafine Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Terbinafine Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Terbinafine Export Data from Intas Pharmaceuticals Limited

Terbinafine Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source